SCHEMBL5529923

SCHEMBL5529923

O=C(NCCCCCOCCOCCOCCOCCOCCO)OCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
TGM2 P21980 1/20 0.61
HTT P42858 1/20 0.60
KEAP1 Q14145 3/20 0.55
NFE2L2 Q16236 3/20 0.55
L3MBTL1 Q9Y468 2/20 0.50
EPHX2 P34913 1/20 0.50
FOLH1 Q04609 3/20 0.49
MAPT P10636 1/20 0.49
DPP8 Q6V1X1 1/20 0.47
DPP7 Q9UHL4 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6759604 0.89 SMN1; SMN2 (0.85) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL21069701 0.89 SMN1; SMN2 (0.85) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL21069619 0.89 SMN1; SMN2 (0.85) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL21071132 0.89 SMN1; SMN2 (0.85) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL17532634 0.89 LMNA (0.79) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL5530584 0.88 LMNA (0.66) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL25030545 0.88 LMNA (0.73) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL1699791 0.88 SMN1; SMN2 (0.88) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL17350181 0.87 LMNA (0.67) LMNASMN1; SMN2TGM2HTTKEAP1
SCHEMBL30980740 0.86 SMN1; SMN2 (0.81) LMNASMN1; SMN2TGM2HTTKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202227-B2 Multifunctional molecular complexes for gene transfer to cells WYETH (US) 2007-04-10 US disclosed
US-20050239204-A1 Multifunctional molecular complexes for gene transfer to cells WYETH (US) 2005-10-27 US disclosed
EP-0789708-B1 MULTIFUNCTIONAL MOLECULAR COMPLEXES FOR GENE TRANSFER TO CELLS WYETH CORP (US) 2004-11-03 EP disclosed
US-20040214328-A9 Multifunctional molecular complexes for gene transfer to cells AMERICAN HOME PRODUCTS CORPORATION (US) 2004-10-28 US disclosed
US-20020155607-A1 Multifunctional molecular complexes for gene transfer to cells AMERICAN HOME PRODUCTS CORPORATION (US) 2002-10-24 US disclosed
US-6379965-B1 NUCLEIC ACID NONCOVALENTLY ASSOCIATED WITH A POLYAMINE COMPOUND THAT IS COVALENTLY ATTACHED TO AN ENDOSOME DISRUPTING AGENT SUCH AS CHOLIC ACID; NONVIRAL VECTORS AMERICAN HOME PRODUCTS CORPORATION 2002-04-30 US disclosed
US-6127170-A GENE THERAPY AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
WO-1996010038-A1 MULTIFUNCTIONAL MOLECULAR COMPLEXES FOR GENE TRANSFER TO CELLS APOLLON, INC. (US) 1996-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214328-A9 Multifunctional molecular complexes for gene transfer to cells SNRPE, TARBP1, HNRNPH3 LMNA 1077/4885SMN1; SMN2 2469/4885TGM2 2069/4885
US-20020155607-A1 Multifunctional molecular complexes for gene transfer to cells SNRPE, TARBP1, HNRNPH3 LMNA 1077/4885SMN1; SMN2 2469/4885TGM2 2069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.